Gel-forming mucin (MUC) (MUC)

Gel-forming mucins are high-molecular-weight, heavily O-glycosylated proteins that serve as the primary structural scaffold of the mucus layers in the respiratory and gastrointestinal tracts. These proteins, primarily MUC2 in the intestines and MUC5AC and MUC5B in the lungs, form large polymers through disulfide linkages, creating a viscoelastic gel that protects underlying epithelia from mechanical damage, pathogens, and chemical insults (Thornton et al., 2008, Annual Review of Physiology). In the airways, mucin hypersecretion and altered rheology are hallmarks of obstructive diseases like COPD and cystic fibrosis, where thick mucus plugs impair lung function and promote infection (Fahy & Dickey, 2010, New England Journal of Medicine). In the gastrointestinal tract, the MUC2-rich layer acts as a critical barrier against commensal bacteria and toxins; its degradation is a key factor in the pathogenesis of ulcerative colitis (Johansson et al., 2013, Nature Reviews Gastroenterology & Hepatology). Pharmacological targeting of these proteins typically involves mucolytic agents like N-acetylcysteine, which break the disulfide bonds within the mucin network to thin the mucus and aid in its removal (Rogers, 2007, Paediatric Respiratory Reviews). Understanding the specific glycosylation patterns and polymerization states of these mucins is essential for developing targeted therapies for mucosal diseases.

Other names

Mucus glycoproteinsSecreted mucinsPolymeric mucinsMUC2MUC5ACMUC5BMUC6MUC19

Mucolytic agents act by reducing the disulfide bridges that cross-link mucin polymers, thereby decreasing the viscosity and elasticity of the mucus gel to facilitate clearance from the airways or gastrointestinal tract (Rogers, 2007, Paediatric Respiratory Reviews).